Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05057546 · ClinicalTrials.gov registry record · Phase 4
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
A Phase 4 study of Aging and Menopause, sponsored by University of Colorado, Denver.
- Active
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05057546: Active Phase 4 study of Aging and Menopause, sponsored by University of Colorado, Denver.
NCT05057546 is a Phase 4 study of Aging and Menopause that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 55 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05057546, a Phase 4 study of Aging and Menopause, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate changes in blood vessels around the heart (e.g., aorta and carotid arteries) and in the brain with the loss of female sex hormones (e.g., estrogen) during the menopause transition. The menopause transition is associated with declines in blood vessel function and increased risk for cardiovascular disease and Alzheimer's disease. Increasing evidence supports an early role for declines in blood vessel function and future development of Alzheimer's disease in aging men and women. This study will learn about the effects of changes in female sex hormones, such as estrogen, during the menopause transition on blood vessel around the heart and in the brain in women.
Primary Outcome
Aortic characteristic impedance and forward pressure wave amplitude
Conditions Studied
Interventions
- DRUG GnRH antagonist
Study Locations (1)
Colorado
- University of Colorado Denver Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2025-07-28 |
| Phase | Phase 4 |
What the registry record for NCT05057546 still lists
NCT05057546 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which GnRH antagonist is the first listed.
NCT05057546 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05057546 about?
NCT05057546 is a clinical study titled "Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)". This study will evaluate changes in blood vessels around the heart (e.g., aorta and carotid arteries) and in the brain with the loss of female sex hormones (e.g., estrogen) during the menopause transition. The menopause transition is associated with declines in blood vessel function and increased ri...
What is the current status of trial NCT05057546?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2021-11-22. Estimated completion is 2025-07-28.
What conditions does trial NCT05057546 study?
This clinical trial studies the following conditions: Aging, Menopause, Women, Estrogen Deficiency.
What interventions are being tested in trial NCT05057546?
The interventions under investigation include: GnRH antagonist (DRUG).
Who is sponsoring clinical trial NCT05057546?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05057546 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05057546's enrollment target sits among peer trials
55 149th of 262 higher than 113 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
RECRUITING · Phase 4
-
Role of Menopause in Thermoregulation
RECRUITING · Phase 4
-
Aging, Beta Blockers, and Thermoregulatory Responses
RECRUITING · Phase 4
-
The Effect of NAD Supplementation on Brain Vascular Health in Aging
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI